PA22-2: a 19-amino acid synthetic peptide; from the laminin A chain sequence [MeSH]
| ID Source | ID |
|---|---|
| PubMed CID | 168510659 |
| MeSH ID | M0191789 |
| Synonym |
|---|
| pa22-2 |
| CS-0882008 |
| HY-P5353 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 8 (100.00%) | 84.16% |
| Substance | Studies | Classes | Roles | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| meclofenamic acid | aminobenzoic acid; organochlorine compound; secondary amino compound | analgesic; anticonvulsant; antineoplastic agent; antipyretic; antirheumatic drug; EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; non-steroidal anti-inflammatory drug | 1991 | 1991 | 33.0 | medium | 0 | 0 | 1 | 0 | 0 | 0 | |
| gold | copper group element atom; elemental gold | 2005 | 2005 | 19.0 | medium | 0 | 0 | 0 | 1 | 0 | 0 | ||
| dibenz(b,f)(1,4)oxazepine-10(11h)-carboxylic acid, 8-chloro-, 2-acetylhydrazide | 1991 | 1991 | 33.0 | medium | 0 | 0 | 1 | 0 | 0 | 0 | |||
| silicon monoxide | silicon oxide | 2000 | 2000 | 24.0 | medium | 0 | 0 | 1 | 0 | 0 | 0 | ||
| arginyl-glycyl-aspartic acid | oligopeptide | 2009 | 2009 | 15.0 | medium | 0 | 0 | 0 | 1 | 0 | 0 | ||
| tyrosyl-isoleucyl-glycyl-seryl-arginine | 1994 | 1994 | 30.0 | medium | 0 | 0 | 1 | 0 | 0 | 0 |
| Condition | Indicated | Studies | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B16 Melanoma | 0 | 1992 | 1992 | 32.0 | medium | 0 | 0 | 1 | 0 | 0 | 0 | |
| Experimental Mammary Neoplasms | 0 | 1991 | 1991 | 33.0 | medium | 0 | 0 | 1 | 0 | 0 | 0 | |
| Fibrosarcoma | 0 | 1994 | 1994 | 30.0 | medium | 0 | 0 | 1 | 0 | 0 | 0 | |
| Invasiveness, Neoplasm | 0 | 1992 | 1992 | 32.0 | medium | 0 | 0 | 1 | 0 | 0 | 0 | |
| Malignant Melanoma | 0 | 1994 | 1994 | 30.0 | medium | 0 | 0 | 1 | 0 | 0 | 0 | |
| Melanoma | 0 | 1994 | 1994 | 30.0 | medium | 0 | 0 | 1 | 0 | 0 | 0 | |
| Metastase | 0 | 1992 | 1992 | 32.0 | medium | 0 | 0 | 1 | 0 | 0 | 0 | |
| Neoplasm Metastasis | 0 | 1992 | 1992 | 32.0 | medium | 0 | 0 | 1 | 0 | 0 | 0 | |
| Pregnancy | 0 | 1991 | 1991 | 33.0 | medium | 0 | 0 | 1 | 0 | 0 | 0 |
| Article | Year |
|---|---|
| Novel neuronal effects of midkine on embryonic cerebellar neurons examined using a defined culture system. Cellular and molecular neurobiology, , Volume: 19, Issue:2 | 1999 |